Loading clinical trials...
Loading clinical trials...
Evaluierung Von Nebenwirkungen Einer Therapie Mit Mitotane Beim Nebennierenkarzinom- Evaluation of Side Effects of Mitotane in Adrenocortical Carcinoma
Mitotane is standard therapy in the treatment of adrenocortical carcinoma. However, many adverse effects are not well documented. Therefore, we are aiming at collecting data about adverse effects in patients treated with mitotane
Age
All ages
Sex
ALL
Healthy Volunteers
No
University Hospital
Würzburg, Germany
Start Date
January 1, 2008
Primary Completion Date
December 1, 2025
Completion Date
December 1, 2027
Last Updated
August 26, 2025
400
ESTIMATED participants
Lead Sponsor
University of Wuerzburg
NCT03050268
NCT00453674
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05563467